QX-010N

N/A

Report date: 2024/04/08 13:44:26

Base Information

Drug NameQX-010N
Drug Alias NameQX-010-NQX010N
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInterleukin 31 receptor inhibitors
TargetsInterleukin 31 receptor
Therapy Area/IndicationsPruritus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesQyuns Therapeutics Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesQyuns Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsPruritus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A